Has Bruno Gallo received payments from drug or device companies?

Yes. Drug and device makers reported $486,517 in general payments to Bruno Gallo across 846 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bruno Gallo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bruno Gallo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bruno Gallo

Neurology · Miami, FLNPI 1235159393

Payments from drug & device makers

$486,517in general payments, 2019–2025

Across 846 payments — averaging $575.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$151K
Teva Pharmaceuticals USA, Inc.$120K
Adamas Pharmaceuticals, Inc.$82K
Acadia Pharmaceuticals Inc$40K
Acorda Therapeutics, Inc$38K
Sunovion Pharmaceuticals Inc.$17K
plus $37K from 43 others

$4,116in research payments, 2019–2025

Across 1 payment — averaging $4116.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$4K

What the payments were for

Consulting fees$18,0796%
Speaking & faculty fees$270,43786%
Travel & lodging$8,7683%
Food & beverage$15,7285%
Education$1920%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	4	$151,414
Teva Pharmaceuticals USA, Inc.	170	$120,430
Adamas Pharmaceuticals, Inc.	164	$82,023
Acadia Pharmaceuticals Inc	75	$39,865
Acorda Therapeutics, Inc	63	$38,261
Sunovion Pharmaceuticals Inc.	50	$17,219
Abbott	43	$16,492
Boston Scientific	5	$12,849
Kyowa Kirin, Inc.	6	$1,780
UCB, Inc.	39	$865
Amgen(2 entities)	31	$732
MDD US Operations, LLC	12	$681
AbbVie(2 entities)	35	$644
Almatica Pharma LLC	16	$371
Neurocrine Biosciences, Inc.	13	$281
Merz North America, Inc.	2	$279
Novartis	13	$273
Tanabe Pharma America, Inc.	9	$183
Biohaven Pharmaceuticals, Inc.	9	$179
SK Life Science, Inc.	10	$177
Harmony Biosciences LLC	5	$170
Eisai Inc.	6	$164
Mallinckrodt Hospital Products Inc.	8	$154
Lilly USA, LLC	8	$134
Biogen	6	$107
Neurelis, Inc.	6	$92
Lundbeck LLC	4	$70
Upsher-smith Laboratories LLC	3	$59
Grifols USA, LLC	3	$57
Livanova USA, Inc.	3	$52
Stryker	1	$50
Vanda Pharmaceuticals Inc.	2	$45
Zyla Life Sciences, Inc.	2	$37
Aprecia Pharmaceuticals, LLC	2	$36
Aquestive Therapeutics, Inc.	2	$35
Vertical Pharmaceuticals, LLC	2	$34
Greenwich Biosciences, Inc.	1	$30
Genentech USA, Inc.	1	$24
Currax Pharmaceuticals LLC	2	$23
Supernus Pharmaceuticals, Inc.	1	$21
Avanir Pharmaceuticals, Inc.	1	$19
Biohaven Pharmaceutical Holding Company Ltd.	1	$18
Banner Life Sciences, LLC	1	$17
Assertio Therapeutics, Inc.	1	$14
Avion Pharmaceuticals	1	$13
Amneal Pharmaceuticals LLC	1	$12
Bristol Myers Squibb	1	$12
Life Molecular Imaging Ltd	1	$12
GE HealthCare	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AUSTEDO$118,139
GOCOVRI$80,698
NUPLAZID$39,017
INBRIJA$37,238
APTIOM$16,496
Infinity DBS Pulse Generators$3,278
Libra and LibraXP DBS IPG$2,901
NOURIANZ$1,709
APOKYN$500
INFINITY$432
XEOMIN$176
ASCLERA$176
Neuromodulation Dspsbls and Accs$126
LONHALA MAGNAIR$117

How this compares

$486,517 in reported general payments places this provider in the 90th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Other neurology in Miami

Michael PfefferMiami$24.5M
Silvia DelgadoMiami$11M
Angel CarrascoMiami$10.3M
Michael BenatarMiami$5.4M
Kottil RammohanMiami$5M
Macarena de la FuenteMiami$4.9M
Victor FaradjiMiami$4M
Brad HerskowitzMiami$3.1M
Mark GoldsteinAtlantis$36.1M
Derrick RobertsonTampa$27.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →